Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.529 USD | +5.48% |
|
-13.28% | -49.63% |
28/05 | Evoke Pharma, Inc. Appoints Mark A. Kowieski as Chief Financial Officer | CI |
14/05 | Evoke Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-49.63% | 45.48L | |
+55.32% | 82TCr | |
+44.05% | 64TCr | |
-6.75% | 35TCr | |
+13.56% | 31TCr | |
+10.68% | 30TCr | |
+16.57% | 24TCr | |
+2.04% | 22TCr | |
+13.31% | 22TCr | |
+8.48% | 17TCr |
- Stock Market
- Equities
- EVOK Stock
- News Evoke Pharma, Inc.
- Evoke Pharma Prices Underwritten Public Offering